Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion — Matthias Bartneck (2020) | RDL Network
Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion
Article 2020 en
Authors
MB
Matthias Bartneck
CK
Christiane Koppe
VF
Viktor Fech
Abstract
1 min read
BACKGROUND & AIMS: Macrophages are key regulators of inflammation and cancer promotion in the liver, and their recruitment and activation is linked to chemokine receptor signaling. However, the exact roles of the chemokine receptors CCR2 and CCR5 for macrophage functions in the liver is obscure. METHODS: mice develop hepatitis and fibrosis after two and liver tumors after six months. RESULTS: immature monocytes or B cells did not reduce liver injury. CONCLUSIONS: mice. While CCR2 controls the recruitment of monocytes to injured livers, CCR5-dependent functions of liver macrophages limit hepatic injury, thereby reducing steatosis and hepatocarcinogenesis.
Henning W. Zimmermann, Sebastian Seidler, Jacob Nattermann, Nikolaus Gaßler, Claus Hellerbrand, Alma Zernecke, Jens J. W. Tischendorf, Tom Luedde, Ralf Weiskirchen, Christian Trautwein, Frank Tacke
Karlin Raja Karlmark, Ralf Weiskirchen, Henning W. Zimmermann, Nikolaus Gaßler, Florent Ginhoux, Christian Weber, Miriam Mérad, Tom Luedde, Christian Trautwein, Frank Tacke
Oliver Krenkel, Tobias Puengel, Olivier Govaere, Ali T. Abdallah, Jana C. Mossanen, Marlene Kohlhepp, Anke Liepelt, Éric Lefebvre, Tom Luedde, Claus Hellerbrand, Ralf Weiskirchen, Thomas Longerich, Ivan G. Costa, Quentin M. Anstee, Christian Trautwein, Frank Tacke
Ekihiro Seki, Samuele De Minicis, Geum‐Youn Gwak, Johannes Kluwe, Sayaka Inokuchi, Christina A. Bursill, Josep M. Llovet, David A. Brenner, Robert F. Schwabe
Francisco Javier Cubero, Erawan Borkham‐Kamphorst, Yulia A. Nevzorova, Mark V. Boekschoten, Nikolaus Gaßler, Ralf Weiskirchen, Tom Luedde, Mathias Heikenwälder, Michael Müller, Christian Liedtke, Christian Trautwein
Discussion(0)
No comments yet. Be the first to comment.